In a highly selected group of patients with advanced melanoma treated with checkpoint blockade immunotherapy, surgical resection of metastases is associated with good outcomes, according to a new study. The study is the first to characterize the outcomes of patients with metastatic melanoma selected for surgery after immunotherapy.
“In the era of improved systemic therapy, checkpoint blockade for metastatic melanoma and the ability to surgically resect all disease